Spain fines pharmaceuticals cartel €5.8 million
Spain's antitrust enforcer has fined the country's only two suppliers of drugs used in nuclear medicine – including a local Novartis subsidiary – for dividing the market and rigging tenders.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10